Description

ReRemicron MR is a formulation of gliclazide in a modified-release tablet form, designed to help manage blood sugar levels in individuals with type 2 diabetes mellitus. This medication is part of the sulfonylurea class of drugs and works primarily by stimulating insulin secretion from the pancreas.

Key Features:

• Active Ingredient:
  • Gliclazide: Each tablet contains 60mg of gliclazide, which helps lower blood glucose levels effectively by enhancing the body’s insulin response.
• Modified Release Formulation:
  • The modified-release (MR) design allows for a gradual release of the active ingredient over time, providing a more consistent and prolonged effect on blood sugar control. This helps reduce the frequency of dosing, often allowing for once-daily administration.
• Mechanism of Action:
  • Gliclazide works by binding to specific receptors on pancreatic beta cells, leading to increased insulin secretion in response to meals. Additionally, it improves insulin sensitivity in peripheral tissues, further aiding in blood sugar management.
• Indications:
  • ReRemicron MR is indicated for the management of type 2 diabetes, particularly in patients who are unable to achieve adequate glycemic control through diet and exercise alone. It can be used alone or in combination with other antidiabetic medications.
• Dosage and Administration:
  • Typically taken once daily, ReRemicron MR should be consumed whole, without crushing or chewing, and ideally taken with breakfast to optimize its blood glucose-lowering effects. The specific dosage should be determined by a healthcare provider based on individual patient needs.
• Side Effects:
  • Common side effects may include:
    • Hypoglycemia (low blood sugar), which can cause symptoms like sweating, shaking, and confusion.
    • Gastrointestinal disturbances, such as nausea or abdominal discomfort.
    • Weight gain in some individuals.
  • Patients should be aware of the signs of hypoglycemia and know how to manage it.
• Precautions:
  • Caution is advised for individuals with liver or kidney impairment, as dosage adjustments may be necessary. Regular monitoring of blood glucose levels is essential for effective management.
• Interactions:
  • Gliclazide may interact with other medications, including anticoagulants and other antidiabetic agents. Patients should inform their healthcare provider about all medications and supplements they are taking.

Conclusion: ReRemicron MR Tablets 60mg (Gliclazide Modified Release) provide an effective option for managing type 2 diabetes through enhanced insulin secretion and improved glucose control. With its once-daily modified-release formulation, it offers convenience and consistency in treatment. As with any medication, it should be used under the guidance of a healthcare professional to ensure optimal results and safety.

• Very secured payment methods
• Shipping will be calculated on checkout
• Please note that price may increase due to exchange rate, ensure updated price before making payment